PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
June 1, 2003Diabetes Care681 citationsOpen Access

The Association Between Cardiovascular Autonomic Neuropathy and Mortality in Individuals With Diabetes

View Full Paper
RMRaelene E. MaserBMBraxton D. MitchellAVAaron I. Vinik

Key Points

  • To examine the relationship between cardiovascular autonomic neuropathy (CAN) and risk of mortality in individuals with diabetes through meta-analysis.
  • Conducted a meta-analysis of 15 studies published from 1966 to 2001.

Structured PICO

Does cardiovascular autonomic neuropathy increase the risk of mortality in individuals with diabetes?

P
Population
Individuals with diabetes from 15 studies
I
Intervention
Presence of cardiovascular autonomic neuropathy (CAN)
C
Comparator
Absence of cardiovascular autonomic neuropathy
O
Outcome
Mortalityhard clinical

Cardiovascular autonomic neuropathy is significantly associated with increased mortality in individuals with diabetes, particularly when defined by multiple abnormal measures.

Abstract

OBJECTIVE: To examine by meta-analysis the relationship between cardiovascular autonomic neuropathy (CAN) and risk of mortality in individuals with diabetes. RESEARCH DESIGN AND METHODS: We searched Medline for English-language articles published from 1966 to 2001. Fifteen studies having a baseline assessment of cardiovascular autonomic function and mortality follow-up were identified. The analyses were stratified according to whether a single abnormality or two or more measures of cardiovascular autonomic function were used to define CAN. A global measure of association (i.e., relative risk) was generated for each group by pooling estimates across the studies using the Mantel-Haenszel procedure. RESULTS: CAN was significantly associated with subsequent mortality in both groups, although the magnitude of the association was stronger for those studies for which two or more measures were used to define CAN. The pooled relative risk for studies that defined CAN with the presence of two or more abnormalities was 3.45 (95% CI 2.66-4.47; P < 0.001) compared with 1.20 (1.02-1.41; P = 0.03) for studies that used one measure. CONCLUSIONS: These results support an association between CAN and increased risk of mortality. The stronger association observed in studies defining CAN by the presence of two or more abnormalities may be due to more severe autonomic dysfunction in these subjects or a higher frequency of other comorbid complications that contributed to their higher mortality risk. Future studies should evaluate whether early identification of subjects with CAN can lead to a reduction in mortality.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Maser et al. (2003) studied this question.

synapsesocial.com/papers/6a139366c1194a2af5044bc5https://doi.org/10.2337/diacare.26.6.1895
Ask AI
Helpful
Bookmark
Share
View Full Paper